Variant Synonymizer: Platform to identify mutations defined in different ways is available now!

VarSy

Over 2,000 gene–disease validation summaries are now available—no login required!

Browse Summaries

ALX3 – Frontorhiny

Frontorhiny is an autosomal recessive frontonasal malformation characterized by ocular hypertelorism (HP:0000316), wide nasal bridge (HP:0000431), short nasal ridge, bifid nasal tip (HP:0000456), broad columella (HP:0010761), widely separated nares and philtrum anomalies. Affected individuals may also present with upper eyelid ptosis and midline dermoid cysts. Early linkage to chromosome 1p13.3 established ALX3 as the causative gene in autosomal recessive frontorhiny.

Homozygous ALX3 variants were first identified in seven unrelated families, each harboring a distinct loss-of-function or homeodomain missense mutation, accounting for seven probands (PMID:19409524). Subsequent analysis of a consanguineous Pakistani pedigree revealed a novel homozygous nonsense variant c.604C>T (p.Gln202Ter) segregating with four affected siblings (PMID:29215096). Segregation in this pedigree included four additional affected relatives.

The ALX3 variant spectrum includes nonsense (c.604C>T (p.Gln202Ter)), splice-site (c.595-2A>T), frameshift (c.578_581del (p.Thr193fs)) and critical homeodomain missense substitutions, all predicted to abolish transcriptional function. No recurrent founder alleles have been reported outside consanguineous populations.

Functional studies in zebrafish demonstrate that combined alx1;alx3 loss-of-function recapitulates human frontonasal and ocular phenotypes, including defective anterior cranial neural crest migration and aberrant anterior segment vasculature. Rescue experiments confirm a requirement for alx3 in craniofacial and ocular development (PMID:35142342).

Integration of robust genetic evidence across eight independent families, confirmed segregation in multiple affected relatives, and concordant animal model data support a definitive gene–disease relationship. This association enables molecular diagnosis, genetic counseling, and inclusion of ALX3 in diagnostic panels for midfacial dysplasias.

Key take-home: Biallelic ALX3 loss-of-function variants unequivocally cause autosomal recessive frontorhiny, supporting definitive clinical utility in diagnosis.

References

  • American Journal of Human Genetics • 2009 • Frontorhiny, a distinctive presentation of frontonasal dysplasia caused by recessive mutations in the ALX3 homeobox gene. PMID:19409524
  • Journal of Human Genetics • 2018 • Exome sequencing revealed a novel nonsense variant in ALX3 gene underlying frontorhiny. PMID:29215096
  • Biology Open • 2022 • Zebrafish models of alx-linked frontonasal dysplasia reveal a role for Alx1 and Alx3 in the anterior segment and vasculature of the developing eye. PMID:35142342

Evidence Based Scoring (AI generated)

Gene–Disease Association

Definitive

Eleven probands from eight unrelated families with autosomal recessive segregation (four affected relatives) and concordant functional model data

Genetic Evidence

Strong

Eleven probands (eight families) with diverse homozygous loss-of-function and missense variants, and segregation in one consanguineous pedigree (four affected)

Functional Evidence

Moderate

Zebrafish alx1;alx3 loss-of-function mutant phenocopies human frontorhiny and rescue experiments confirm requirement for ALX3